Tranexamic Acid for Prevention of Postpartum Haemorrhage: a Dose-finding Study

PHASE3CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 11, 2018

Primary Completion Date

March 14, 2019

Study Completion Date

August 19, 2019

Conditions
Post Partum Hemorrhage
Interventions
DRUG

Tranexamic Acid

A single dose of intravenous TxA in 100ml of 0.9% sodium chloride at 50mg/min, via a dose-escalation design

Trial Locations (1)

M5G1Z5

Mount Sinai Hospital, Toronto

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

Sinai Health System

OTHER

collaborator

University of Toronto

OTHER

collaborator

University of Waterloo

OTHER

collaborator

University Health Network, Toronto

OTHER

lead

Mount Sinai Hospital, Canada

OTHER

NCT03565276 - Tranexamic Acid for Prevention of Postpartum Haemorrhage: a Dose-finding Study | Biotech Hunter | Biotech Hunter